Targeted CUL4A inhibition synergizes with cisplatin to yield long-term survival in models of head and neck squamous cell carcinoma through a DDB2-mediated mechanism.

Jones TM, Espitia CM, Ooi A, Bauman JE, Carew JS, Nawrocki ST. "Targeted CUL4A inhibition synergizes with cisplatin to yield long-term survival in models of head and neck squamous cell carcinoma through a DDB2-mediated mechanism." Cell Death Dis. 2022;13(4):350.